{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:35:06Z","timestamp":1778942106039,"version":"3.51.4"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/pas.0000000000000309","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T20:12:02Z","timestamp":1407960722000},"page":"1349-1359","source":"Crossref","is-referenced-by-count":19,"title":["Intracellular TCR-signaling Pathway"],"prefix":"10.1097","volume":"38","author":[{"given":"Claudio","family":"Agostinelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishvesh","family":"Shende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse U.","family":"Akarca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Fuligni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Righi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiano","family":"Spagnolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Paolo","family":"Piccaluga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano A.","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Marafioti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210131","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nri3403","article-title":"T cell receptor signalling networks: branched, diversified and bounded.","volume":"13","author":"Brownlie","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"R2-6-20210131","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/35100523","article-title":"Positive and negative regulation of T-cell activation by adaptor proteins.","volume":"1","author":"Koretzky","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"R3-6-20210131","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1038\/sj.onc.1204771","article-title":"The role of Gads in hematopoietic cell signalling.","volume":"20","author":"Liu","year":"2001","journal-title":"Oncogene"},{"key":"R4-6-20210131","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.4049\/jimmunol.173.3.1711","article-title":". The Gads (GrpL) adaptor protein regulates T cell homeostasis.","volume":"173","author":"Yankee","year":"2004","journal-title":"J Immunol"},{"key":"R5-6-20210131","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.4049\/jimmunol.175.7.4483","article-title":"Phosphotyrosine binding-mediated oligomerization of downstream of tyrosine kinase (Dok)-1 and Dok-2 is involved in CD2-induced Dok phosphorylation.","volume":"175","author":"Boulay","year":"2005","journal-title":"J Immunol"},{"key":"R6-6-20210131","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1084\/jem.20060650","article-title":". T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2.","volume":"203","author":"Dong","year":"2006","journal-title":"J Exp Med"},{"key":"R7-6-20210131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1074-7613(00)80584-1","article-title":". FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation.","volume":"9","author":"Nelms","year":"1998","journal-title":"Immunity"},{"key":"R8-6-20210131","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1084\/jem.194.3.265","article-title":". Phosphoinositide 3-kinase-dependent membrane recruitment of p62(dok) is essential for its negative effect on mitogen-activated protein (MAP) kinase activation.","volume":"194","author":"Zhao","year":"2001","journal-title":"J Exp Med"},{"key":"R9-6-20210131","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/MCB.02011-06","article-title":". RIAM links the ADAPSKAP-55 signaling module to Rap1, facilitating T-cell-receptor-mediated integrin activation.","volume":"27","author":"Menasche","year":"2007","journal-title":"Mol Cell Biol"},{"key":"R10-6-20210131","doi-asserted-by":"crossref","first-page":"e1718","DOI":"10.1371\/journal.pone.0001718","article-title":". Adaptor SKAP-55 binds p21 activating exchange factor RasGRP1 and negatively regulates the p21-ERK pathway in T-cells.","volume":"3","author":"Schneider","year":"2008","journal-title":"PLoS One"},{"key":"R11-6-20210131","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1006\/bbrc.1998.9637","article-title":". RA70 is a src kinase-associated protein expressed ubiquitously.","volume":"252","author":"Kouroku","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R12-6-20210131","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nri1591","article-title":"TEC-family kinases: regulators of T-helper-cell differentiation.","volume":"5","author":"Schwartzberg","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R13-6-20210131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/385093a0","article-title":". Regulatory intramolecular association in a tyrosine kinase of the Tec family.","volume":"385","author":"Andreotti","year":"1997","journal-title":"Nature"},{"key":"R14-6-20210131","doi-asserted-by":"crossref","first-page":"a002287","DOI":"10.1101\/cshperspect.a002287","article-title":". T-cell signaling regulated by the Tec family kinase, Itk.","volume":"2","author":"Andreotti","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R15-6-20210131","first-page":"29","article-title":"PKC isotype functions in T lymphocytes.","volume":"3","author":"Baier","year":"2007","journal-title":"Ernst Schering Found Symp Proc"},{"key":"R16-6-20210131","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":". Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"key":"R17-6-20210131","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20092042","article-title":". The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.","volume":"207","author":"Pechloff","year":"2010","journal-title":"J Exp Med"},{"key":"R18-6-20210131","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3816\/CLC.2004.n.032","article-title":". Expression levels of protein kinase C-alpha in non-small-cell lung cancer.","volume":"6","author":"Lahn","year":"2004","journal-title":"Clin Lung Cancer"},{"key":"R19-6-20210131","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.phrs.2007.04.001","article-title":"Classical PKC isoforms in cancer.","volume":"55","author":"Martiny-Baron","year":"2007","journal-title":"Pharmacol Res"},{"key":"R20-6-20210131","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1046\/j.1600-6143.2003.00230.x","article-title":"Hematopoietic adaptors in T-cell signaling: potential applications to transplantation.","volume":"3","author":"Rudd","year":"2003","journal-title":"Am J Transplant"},{"key":"R21-6-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000080279","article-title":". Protein kinase C alpha expression in breast and ovarian cancer.","volume":"67","author":"Lahn","year":"2004","journal-title":"Oncology"},{"key":"R22-6-20210131","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":". Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"key":"R23-6-20210131","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1200\/JCO.2012.42.5611","article-title":". Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.","volume":"31","author":"Piccaluga","year":"2013","journal-title":"J Clin Oncol"},{"key":"R24-6-20210131","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1182\/blood-2007-10-117531","article-title":". Novel markers of normal and neoplastic human plasmacytoid dendritic cells.","volume":"111","author":"Marafioti","year":"2008","journal-title":"Blood"},{"key":"R25-6-20210131","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1182\/blood-2009-06-227017","article-title":". Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells.","volume":"115","author":"Basso","year":"2010","journal-title":"Blood"},{"key":"R26-6-20210131","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20080809","article-title":". Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis.","volume":"205","author":"Brune","year":"2008","journal-title":"J Exp Med"},{"key":"R27-6-20210131","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":". Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"key":"R28-6-20210131","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","article-title":". Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.","volume":"67","author":"Piccaluga","year":"2007","journal-title":"Cancer Res"},{"key":"R29-6-20210131","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":". Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J Clin Invest"},{"key":"R30-6-20210131","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3324\/haematol.12754","article-title":". Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.","volume":"93","author":"Piccaluga","year":"2008","journal-title":"Haematologica"},{"key":"R31-6-20210131","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":". Summaries of Affymetrix GeneChip probe level data.","volume":"31","author":"Irizarry","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"R32-6-20210131","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods.","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"R33-6-20210131","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/labinvest.2010.121","article-title":". Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcoma.","volume":"90","author":"Mashima","year":"2010","journal-title":"Lab Invest"},{"key":"R34-6-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000089458","article-title":"The role of protein kinase C-alpha in hematologic malignancies.","volume":"115","author":"Lahn","year":"2006","journal-title":"Acta Haematol"},{"key":"R35-6-20210131","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2004-03-1037","article-title":". Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling.","volume":"104","author":"Bonzheim","year":"2004","journal-title":"Blood"},{"key":"R36-6-20210131","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3324\/haematol.2012.081935","article-title":". CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.","volume":"98","author":"Bisig","year":"2013","journal-title":"Haematologica"},{"key":"R37-6-20210131","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":". ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"R39-6-20210131","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1440-1827.2004.01612.x","article-title":"Characterization of expression of protein kinase C isozymes in human B-cell lymphoma: relationship between its expression and prognosis.","volume":"54","author":"Kamimura","year":"2004","journal-title":"Pathol Int"},{"key":"R40-6-20210131","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/cimm.1999.1549","article-title":". Protein kinase C-alpha is essential for Ramos-BL B cell survival.","volume":"196","author":"Keenan","year":"1999","journal-title":"Cell Immunol"},{"key":"R41-6-20210131","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1074\/jbc.M109068200","article-title":". Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation.","volume":"277","author":"Podar","year":"2002","journal-title":"J Biol Chem"},{"key":"R42-6-20210131","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/cncr.11909","article-title":". A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced ovarian carcinoma.","volume":"100","author":"Advani","year":"2004","journal-title":"Cancer"},{"key":"R43-6-20210131","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1200\/JCO.2005.04.3299","article-title":". Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.","volume":"24","author":"Paz-Ares","year":"2006","journal-title":"J Clin Oncol"},{"key":"R44-6-20210131","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.lungcan.2005.12.012","article-title":". Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer.","volume":"52","author":"Ritch","year":"2006","journal-title":"Lung Cancer"},{"key":"R45-6-20210131","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10637-005-6736-x","article-title":". Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advancedmetastatic non-small cell lung cancer.","volume":"23","author":"Vansteenkiste","year":"2005","journal-title":"Invest New Drugs"},{"key":"R46-6-20210131","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10637-005-2906-0","article-title":". A phase I trial of aprinocarsen (ISIS 3521LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer.","volume":"23","author":"Advani","year":"2005","journal-title":"Invest New Drugs"},{"key":"R47-6-20210131","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1215\/S1152851703000353","article-title":". Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas.","volume":"7","author":"Grossman","year":"2005","journal-title":"Neuro Oncol"},{"key":"R48-6-20210131","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1124\/mol.112.079889","article-title":". Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.","volume":"82","author":"Guo","year":"2012","journal-title":"Mol Pharmacol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:43:57Z","timestamp":1620967437000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201410000-00006"}},"subtitle":["Novel Markers for Lymphoma Diagnosis and Potential Therapeutic Targets"],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000309","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}